Virender Rehan to Lung Injury
This is a "connection" page, showing publications Virender Rehan has written about Lung Injury.
Connection Strength
2.460
-
Combination of pioglitazone, a PPAR? agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung injury in adult mice lung explants. Pulm Pharmacol Ther. 2023 06; 80:102209.
Score: 0.780
-
A Combination of the Aerosolized PPAR-? Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats. Neonatology. 2018; 113(4):296-304.
Score: 0.549
-
Nebulized PPAR? agonists: a novel approach to augment neonatal lung maturation and injury repair in rats. Pediatr Res. 2014 May; 75(5):631-40.
Score: 0.415
-
Evidence for in vivo nicotine-induced alveolar interstitial fibroblast-to-myofibroblast transdifferentiation. Exp Lung Res. 2010 Sep; 36(7):390-8.
Score: 0.328
-
Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol. 2010 Nov; 299(5):L672-80.
Score: 0.327
-
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol. 2006 Jun; 41(6):558-69.
Score: 0.061